Diebold Nixdorf (DBD) Tops Q1 EPS by 9c, Revenues Beat; Offers FY21 Revenues Outlook
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $63.37 +0.27%
Financial Fact:
Diluted weighted-average shares outstanding: 65.2M
Today's EPS Names:
MLKN, KBH, WOR, More
Financial Fact:
Diluted weighted-average shares outstanding: 65.2M
Today's EPS Names:
MLKN, KBH, WOR, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q1 EPS of $0.29, $0.09 better than the analyst estimate of $0.20. Revenue for the quarter came in at $943.9 million versus the consensus estimate of $941.22 million.
GUIDANCE:
Diebold Nixdorf sees FY2021 revenue of $4-4.1 billion, versus the consensus of $4.09 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Morgan Stanley Upgrades Coal India Ltd (COAL:IN) to Overweight
- Goldman Sachs Upgrades SK Innovation Co Ltd (096770:KS) to Neutral
Create E-mail Alert Related Categories
Corporate News, Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
